Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nature. 2005 Dec 15;438(7070):967-74.

Angiogenesis as a therapeutic target.

Author information

  • 1Genentech, 1 DNA Way, South San Francisco, California 94080, USA. nf@gene.com

Abstract

Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration. Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries. Therapeutic angiogenesis (promoting new vessel growth to treat ischaemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first.

PMID:
16355214
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk